echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > DCR: CD4/CD8 ratio can be used as a basis for high-grade anal dysplasia and high risk of anal cancer among HIV-infected patients

    DCR: CD4/CD8 ratio can be used as a basis for high-grade anal dysplasia and high risk of anal cancer among HIV-infected patients

    • Last Update: 2021-08-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    In the United States, HIV veterans in the infection rate is highest among persons of all proportion


     


     


    Figure: The correlation between CD4/CD8 and high-grade anal dysplasia and high-risk of anal cancer in HIV patients

     


    This study found that 5% of HIV-positive people have advanced anal cancer


     

    Original source:

    Sanger, Cristina.


    Prevalence of High-Grade Anal Dysplasia and Anal Cancer in Veterans Living With HIV and CD4/CD8 Ratio as a Marker For Increased Risk.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.